Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8156
Reference
Name
National Patient Safety Alert – Shortage of Pancreatic Enzyme Replacement Therapy (PERT)
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
National Patient Safety Alert
Shortages
Description
There are limited supplies of pancreatic enzyme replacement therapies (PERT).
Creon® 10,000 and 25,000 capsules are in limited supply until 2026.
Nutrizym® 22 capsules are out of stock until mid-August 2024.
Pancrex V® capsules and powder remain available but are unable to support an increase in demand.
The supply disruption of Creon® capsules is due to limited availability of active pharmaceutical ingredients and manufacturing constraints to produce the volumes required to meet demand.
The supply disruption for Nutrizym® 22 capsules has been caused by a manufacturing issue and increased demand because of the Creon® supply issue.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2024-05-24 09:19:00
Click to go back to homepage